Evidence map›Paper›PMID 27649746›Full record

ArticleCell cycle (Georgetown, Tex.)2016

A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.

Nana Zheng, Xiangpeng Dai, Zhiwei Wang, Wenyi Wei

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nana Zhenga The Cyrus Tang Hematology Center and Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University , Suzhou , P. R. China.
Xiangpeng Daib Department of Pathology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Zhiwei Wanga The Cyrus Tang Hematology Center and Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University , Suzhou , P. R. China.
Wenyi Weib Department of Pathology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Beth Israel Deaconess Medical Center · USFirst Affiliated Hospital of Soochow University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Set8 is critically involved in transcription regulation, cell cycle progression and genomic stability. Emerging evidence has revealed that E3 ubiquitin ligases such as CRL4

Indexed as

Cell CycleProteolysisAnimalsbeta-Transducin Repeat-Containing ProteinsHistone-Lysine N-MethyltransferaseHumansModels, Biologicalbeta-Transducin Repeat-Containing ProteinsHistone-Lysine N-MethyltransferaseCell cyclecell proliferationDNA damageSet8Ubiquitinβ-TRCP

Identifiers

PMID27649746
PMCPMC5134714
OpenAlexW2523423668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.